Announced
Completed
Synopsis
Impilo, a Nordic investment company, completed the investment in Qufora, which produces clinical aids for patients with chronic bowel conditions. Financial terms were not disclosed. "We have followed Qufora for several years and are highly impressed by the company’s development, which is largely grounded in Qufora’s strong values, strategy, and culture. This is encapsulated by a highly skilled management team and staff who show a deep passion for Qufora’s products and mission. With this partnership, we can jointly accelerate the company’s future expansion," Nicholas Hooge, Impilo Partner.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.